Related Experiment Video

Updated: Jul 19, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

RASSF1A suppresses oncogenic H-Ras-induced c-Jun N-terminal kinase activation

Young A Yoo1, Ah Ram Na, Myeong-Sok Lee

  • 1Graduate School of Medicine, Korea University College of Medicine, Korea University, Seoul 136-705, Korea.

International Journal of Oncology
|November 8, 2006
PubMed

Insights

The tumor suppressor RASSF1A blocks oncogenic Ras-induced JNK activation, preventing Ras-driven cancer cell transformation and p27Kip1 down-regulation. This highlights RASSF1A

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Signaling

Background:

  • Constitutive JNK activation is linked to Ras-induced cellular transformation.
  • The tumor suppressor RASSF1A normally down-regulates activated JNK.
  • Oncogenic Ras proteins promote cell proliferation and survival.

Purpose of the Study:

  • To investigate if RASSF1A inhibits JNK activation triggered by oncogenic Ras.
  • To determine the role of RASSF1A in regulating Ras-mediated signaling pathways.

Main Methods:

  • Exogenous expression of H-RasG12V and RASSF1A in cancer cell lines.
  • Analysis of JNK phosphorylation levels.
  • Assessment of p27Kip1 protein levels.
  • Utilized JNK siRNA to confirm pathway involvement.

Main Results:

  • H-RasG12V expression induced JNK phosphorylation.
  • Co-expression of RASSF1A suppressed H-RasG12V-induced JNK activation.
  • RASSF1A reversed H-RasG12V-induced p27Kip1 down-regulation, an effect mimicked by JNK siRNA.

Conclusions:

  • RASSF1A inhibits oncogenic Ras-induced JNK activation.
  • RASSF1A blocks JNK-mediated down-regulation of p27Kip1.
  • RASSF1A exerts tumor-suppressive effects by inhibiting the Ras-JNK pathway.

More Related Videos

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...